Clinical Effectiveness of Secondary Interventions for Restenosis Following Renal Artery Angioplasty and Stenting: Does it Help, Hurt or Even Make a Difference?

Benjamin S. Brooke, Samuel T. Simone, Philip P. Goodney, Randall R. DeMartino, Daniel B. Walsh, David H. Stone, Richard J. Powell, Jack L. Cronenwett, Brian W. Nolan
2012 Journal of Vascular Surgery  
patients, and 1.4% for blacks (P ϭ .0002). There was a longer operating time (P Ͻ .001) and total length of stay (P Ͻ .001), more postoperative pneumonias (P ϭ .0049), unplanned intubations (P Ͻ .001), ventilator dependence (P Ͻ .001), cardiac arrests (P Ͻ .001), bleeding requiring transfusions (P ϭ .0024), and returns to the operating room (P ϭ .0021) among black patients. Multivariate logistic regression identified black race as an independent risk factor for 30-day mortality (relative risk,
more » ... .9; P ϭ .0007). Black patients also had more in-hospital deaths than white patients (73.7% vs 43.1%, P ϭ .001). The rate of postdischarge strokes did not differ between the groups: 36.4% of all strokes occurred after discharge at a mean of 8.3 days and 54.3% of deaths occurred after discharge at a mean of 11 days. Conclusions: Black race is identified as an independent risk factor for 30-day mortality after CEA. A significant proportion of strokes and deaths occur after discharge in both racial groups evaluated. Abstracts 1477 Conclusions: Patients undergoing secondary interventions for recurrent RAS have comparable outcomes as those for primary interventions. These data suggest that repeated endovascular procedures for renal artery restenosis can be safely undertaken while maintaining similar expectations for clinical improvement.
doi:10.1016/j.jvs.2012.08.077 fatcat:o2dacnm4djcvbcp2zgwztzvy2y